Showing results (391-400 of 753) with videos related to
Sort By:
Pageof 76
Neuro-Oncology Practice|December 29, 2025
Presenting clinical and radiographic features of diffuse glioma molecular subtypes in accordance with the 2021 CNS5 WHO classificationJasmin Jo, Mark Willy L Mondia, Josephine Arewa, et al.Biomedical Physics & Engineering Express|August 2, 2024
An end-to-end deep learning pipeline to derive blood input with partial volume corrections for automated parametric brain PET mappingRugved Chavan, Gabriel Hyman, Zoraiz Qureshi, et al.The Lancet. Oncology|June 13, 2015
Response assessment criteria for brain metastases: proposal from the RANO groupNancy U Lin, Eudocia Q Lee, Hidefumi Aoyama, et al.Journal of Neuro-Oncology|March 1, 2021
Clinical, radiological and genomic features and targeted therapy in BRAF V600E mutant adult glioblastomaMary Jane Lim-Fat, Kun Wei Song, J Bryan Iorgulescu, et al.Neuro-Oncology|March 8, 2011
A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03Fabio M Iwamoto, Kathleen R Lamborn, John G Kuhn, et al.Journal of Neuro-Oncology|November 30, 2018
Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomideMichael Dworkin, William Mehan, Andrzej Niemierko, et al.The Oncologist|December 7, 2013
Low incidence of pseudoprogression by imaging in newly diagnosed glioblastoma patients treated with cediranib in combination with chemoradiationMarco C Pinho, Pavlina Polaskova, Jayashree Kalpathy-Cramer, et al.Journal of Neuro-Oncology|September 10, 2020
Automated apparent diffusion coefficient analysis for genotype prediction in lower grade glioma: association with the T2-FLAIR mismatch signEric Aliotta, Sunil W Dutta, Xue Feng, et al.Expert Review of Vaccines|June 12, 2013
An update on vaccine therapy and other immunotherapeutic approaches for glioblastomaDavid A Reardon, Kai W Wucherpfennig, Gordon Freeman, et al.Breast Cancer Research and Treatment|October 5, 2024
Intracranial outcomes following neurosurgical resection in patients with brain metastases secondary to HER2-positive breast cancer versus other subtypesNarmeen S Rashid, Nayan Lamba, Paul J Catalano, et al.Pageof 76